Form 4: Enfusion Inc. Executive Matthew Campobasso Reports Changes in Beneficial Ownership
SEC Form 4
Matthew Campobasso, General Counsel of Enfusion, Inc., reports acquisition and disposal of Class A Common Stock related to restricted stock units and tax obligations.
Summary
- On March 1, 2024, Matthew Campobasso, General Counsel of Enfusion, Inc., reported changes in beneficial ownership of the company's Class A Common Stock.
- Campobasso acquired 23,069 shares of Class A Common Stock at $0 related to restricted stock units (RSUs) that vest in installments from March 1, 2025, to March 1, 2028.
- He also acquired 3,124 fully vested shares at $8.67 per share.
- Additionally, 1,081 shares were disposed of at $8.67 per share to cover tax withholding obligations.
- Following these transactions, Campobasso beneficially owns 55,952 shares of Class A Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations. There are no indications of unusual or concerning activity.
Positives
- The acquisition of restricted stock units and vested shares indicates continued alignment of the executive's interests with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices involving stock-based awards.
Comparison to Industry Standards
- Stock-based compensation is a common practice among publicly traded companies, particularly in the technology sector, to incentivize executives and align their interests with shareholders.
- The vesting schedule of the restricted stock units (RSUs) is typical, with vesting occurring over a multi-year period.
- Companies like BlackLine, Guidewire Software, and Workiva also utilize stock options and RSUs as part of their executive compensation packages.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they primarily concern internal compensation arrangements.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of earliest transaction (acquisition/disposal of shares). |
| 03/01/2025 | First vesting date for 5,768 restricted stock units. |
| 03/01/2026 | Second vesting date for 5,767 restricted stock units. |
| 03/01/2027 | Third vesting date for 5,767 restricted stock units. |
| 03/01/2028 | Final vesting date for 5,767 restricted stock units. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.